Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer
Publication Date: January 24, 2024
Last Updated: February 2, 2024
GUIDELINE STATEMENTS
Diagnosis
1. At the time of resection of suspected bladder cancer, a clinician should perform a thorough cystoscopic examination of a patient’s entire urethra and bladder that evaluates and documents tumor size, location, configuration, number, and mucosal mabnormalities.
(Clinical Principle, )322859
2. At initial diagnosis of a patient with bladder cancer, a clinician should perform complete visual resection of the bladder tumor(s), when technically feasible.
(Clinical Principle, )322859
3. A clinician should perform upper urinary tract imaging as a component of the initial evaluation of a patient with bladder cancer.
(Clinical Principle, )322859
4. In a patient with a history of NMIBC with normal cystoscopy and positive cytology, a clinician should consider prostatic urethral biopsies and upper tract imaging, as well as enhanced cystoscopic techniques (blue light cystoscopy, when available), ureteroscopy, or random bladder biopsies.
(Expert Opinion, )322859
Title
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer
Authoring Organizations
American Urological Association
Society of Urologic Oncology